XML 20 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
OPERATING ACTIVITIES - continuing operations      
Net income (loss) $ (100,345,000) $ (27,820,000) $ 202,041,000
(Income) loss from discontinued operations, including gain on sale, net of tax 0 (14,026,000) (232,339,000)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:      
Depreciation and amortization 19,751,000 14,069,000 11,701,000
Equity-based compensation 27,034,000 23,889,000 6,411,000
Impairment related and other 41,238,000 1,092,000 0
Other (income) loss (1,692,000) (5,300,000) 4,210,000
Equity (income) loss 0 776,000 2,963,000
Deferred income taxes 258,000 (4,510,000) 0
Income tax (benefit) expense related to income from discontinued operations 0 (8,934,000) (17,571,000)
Changes in operating assets and liabilities - net of acquisitions:      
Accounts receivable, net 3,107,000 (2,024,000) (3,445,000)
Prepaid expenses and other assets (835,000) 595,000 (817,000)
Accounts payable (1,270,000) (65,000) (1,358,000)
Accrued expenses 2,560,000 252,000 1,192,000
Accrued compensation and benefits 3,010,000 510,000 3,310,000
Deferred revenue 7,827,000 7,765,000 5,325,000
Other liabilities (1,202,000) (488,000) 330,000
Cash flows provided by (used in) operating activities (559,000) (14,219,000) (18,047,000)
INVESTING ACTIVITIES - continuing operations      
Capital expenditures, net (5,530,000) (3,677,000) (1,243,000)
Change in restricted cash (1,074,000) 193,000 (834,000)
Proceeds from sales/distributions of ownership interests 1,415,000 33,822,000 388,968,000
Proceeds from marketable securities 0 0 760,000
Ownership acquisition, net of cash acquired (3,578,000) (215,225,000) (14,638,000)
Increase in cash due to consolidation of subsidiaries 0 0 1,153,000
Cash flows provided by (used in) investing activities (8,767,000) (184,887,000) 374,166,000
FINANCING ACTIVITIES – continuing operations      
Acquisition of noncontrolling interest in subsidiary equity (10,319,000) (878,000) (15,430,000)
Contingent consideration payments (1,870,000) 0 0
Borrowings of short-term debt 820,000 0 4,900,000
Repayment of long-term debt and capital lease obligations (24,000) (12,641,000) (2,480,000)
Purchase of treasury stock (1,704,000) (12,809,000) (12,025,000)
Tax withholdings related to equity-based awards (4,277,000) (5,029,000) (12,023,000)
Cash received for stock option exercises 15,000 94,000 11,000
Other financing activities (9,000) 0 (73,000)
Cash flows provided by (used in) financing activities (17,368,000) (31,263,000) (37,120,000)
Effect of exchange rate on cash flows and cash equivalents (127,000) 0  
Discontinued operations:      
Cash flows provided by (used in) operating activities 0 0 5,216,000
Cash flows provided by (used in) investing activities 0 (1,153,000) (2,302,000)
Cash flows provided by (used in) financing activities 0 0 (8,129,000)
Net increase (decrease) in cash and cash equivalents from discontinued operations 0 (1,153,000) (5,215,000)
Net increase (decrease) in cash and cash equivalents (26,821,000) (231,522,000) 313,784,000
Cash and cash equivalents at beginning of period 103,134,000 334,656,000 20,872,000
Cash and cash equivalents at end of period - continuing operations $ 76,313,000 $ 103,134,000 $ 334,656,000